RubiN – continuous care in regional networks: a study protocol for a prospective controlled trial

Simone Gloystein*, Friederike Thomé, Katja Goetz, Nicole Warkentin, Karola Mergenthal, Fabian Engler, Volker Amelung, Matthias Arnold, Felix Freigang, Ann Kathrin Klähn, Sonja Laag, Neeltje van den Berg

*Corresponding author for this work
1 Citation (Scopus)

Abstract

Background: The health care situation of geriatric patients is often multifaceted, complex and often overlaps with social living conditions. Due to the lack of cross-sectoral and interprofessional health care geriatric patients often, receive insufficient care. Only a holistic view enables a comprehensive evaluation of the complex health risks, but also the potential to preserve the health of geriatric patients. The implementation of cross-sectoral, multi-professional case management could reduce the gaps in care, improve the autonomy of the geriatric patients in their own homes, and allow them to retain it as long as possible. The “RubiN” project examines the effects of multi-professional, cross-sectoral and assessment-based case management on the quality of the care of geriatric patients. The results of the study aim to show whether geriatric patients receive better care using case management than patients who receive standard health care. In addition, data on the effects of case management on practices of general practitioners (GP), the satisfaction with the care concept amongst the case managers, patients and relatives will be collected. Furthermore, a health economic analysis will be carried out. Methods: The project is designed as a prospective controlled study and compares geriatric patients from practice networks in different regions in Germany. Inclusion criteria are: Age ≥ 70 years and care requirements from two different care complexes (identified with the screening instrument ‘Angelina’-questionnaire). The intervention is the use of a geriatric case management, where health care is organised based on patient-specific care requirements. Five practice networks of physicians will implement the intervention (n = 3200 patients) and three practice networks will serve as the control group (n = 1200 patients). The primary endpoint is the ability to manage activities of daily living, measured using the Barthel Index. The patients in the intervention group receive geriatric case management and the patients in the control networks receive standard care (“care as usual”). The analysis of the primary data, which is pseudonymised, occurs according to the intention-to-treat principle. For this purpose, the endpoints will be analysed using a group comparison after 12 months. For the health economic analysis, secondary data from the statutory health insurance providers will be included in the analysis, in addition to the primary data. Data for the analysis of the effects the concept has on the GP practices as well as on the satisfaction of the project participants will be collected with questionnaires and interviews with experts. Discussion: The implementation of cross-sectoral and interdisciplinary geriatric case management has been a topic of discussion for years, whereby positive effects have already been-shown. This planned study will be the first evaluation of the effect of case management for geriatric patients with a very large sample. In addition, the effects of case management on the GP practices and also on the relatives of the geriatric patients will be shown. It is intended that the study results pave the way for a widespread implementation of this concept. Trial registration: German Clinical Trials Register, ID: DRKS00016642. Registered on 29 October 2019 - Retrospectively registered.

Original languageEnglish
Article number183
JournalBMC Geriatrics
Volume21
Issue number1
Pages (from-to)183
DOIs
Publication statusPublished - 16.03.2021

Research Areas and Centers

  • Research Area: Center for Population Medicine and Public Health (ZBV)

Fingerprint

Dive into the research topics of 'RubiN – continuous care in regional networks: a study protocol for a prospective controlled trial'. Together they form a unique fingerprint.

Cite this